The Claim
Weight loss resolves liver inflammation and improves hepatic insulin sensitivity in mice and humans, but visceral adipose tissue inflammation and insulin resistance remain unchanged despite normalization of adipocyte size and body weight.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When mice and humans lose weight, liver inflammation decreases and insulin sensitivity in the liver improves, but inflammation and insulin resistance in visceral fat tissue do not improve even when fat cells shrink and body weight returns to normal.
See the scientific wording
In mice and humans, weight loss resolves liver inflammation and improves hepatic insulin sensitivity, but visceral adipose tissue inflammation and insulin resistance remain largely unchanged despite normalization of adipocyte size and body weight.
After weight loss, fat cells around the organs stay swollen with immune cells that keep releasing inflammatory signals, which block insulin from working properly in those fat cells. Meanwhile, the liver clears out its inflammation and immune cells quickly, allowing insulin to work normally again. The pancreas keeps pumping out extra insulin to compensate for the fat tissue's resistance, which hides the problem by keeping blood sugar low even though the fat tissue is still resistant.
What the research says
1 studyWhen people or mice lose weight, their liver gets healthier and works better with insulin, but the fat around their organs stays inflamed and stubborn—even if the fat cells get smaller. Weight loss helps the liver, but not the belly fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.